AlphaMark Advisors’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $50K | Buy |
96
+72
| +300% | +$37.5K | 0.02% | 245 |
|
|
2024
Q3 | $12K | Hold |
24
| – | – | ﹤0.01% | 491 |
|
|
2024
Q2 | $11K | Sell |
24
-10
| -29% | -$3.98K | ﹤0.01% | 519 |
|
|
2024
Q1 | $14K | Sell |
34
-2
| -6% | -$756 | ﹤0.01% | 487 |
|
|
2023
Q4 | $12K | Sell |
36
-27
| -43% | -$8.05K | ﹤0.01% | 503 |
|
|
2023
Q3 | $18K | Buy |
63
+9
| +17% | +$2.81K | 0.01% | 444 |
|
|
2023
Q2 | $18K | Hold |
54
| – | – | 0.01% | 326 |
|
|
2023
Q1 | $14K | Hold |
54
| – | – | 0.01% | 362 |
|
|
2022
Q4 | $14K | Hold |
54
| – | – | 0.01% | 336 |
|
|
2022
Q3 | $10K | Hold |
54
| – | – | 0.01% | 412 |
|
|
2022
Q2 | $11K | Hold |
54
| – | – | 0.01% | 384 |
|
|
2022
Q1 | $16K | Hold |
54
| – | – | 0.01% | 359 |
|
|
2021
Q4 | $19K | Hold |
54
| – | – | 0.01% | 335 |
|
|
2021
Q3 | $18K | Hold |
54
| – | – | 0.01% | 344 |
|
|
2021
Q2 | $17K | Hold |
54
| – | – | 0.01% | 349 |
|
|
2021
Q1 | $13K | Hold |
54
| – | – | 0.01% | 367 |
|
|
2020
Q4 | $15K | Sell |
54
-6
| -10% | -$1.49K | 0.01% | 330 |
|
|
2020
Q3 | $14K | Sell |
60
-27
| -31% | -$6.06K | 0.01% | 316 |
|
|
2020
Q2 | $17K | Sell |
87
-120
| -58% | -$21.5K | 0.01% | 297 |
|
|
2020
Q1 | $34K | Hold |
207
| – | – | 0.02% | 209 |
|
|
2019
Q4 | $41K | Hold |
207
| – | – | 0.02% | 211 |
|
|
2019
Q3 | $37K | Sell |
207
-6
| -3% | -$1.04K | 0.02% | 218 |
|
|
2019
Q2 | $37K | Hold |
213
| – | – | 0.02% | 220 |
|
|
2019
Q1 | $41K | Sell |
213
-12
| -5% | -$2.13K | 0.02% | 208 |
|
|
2018
Q4 | $36K | Sell |
225
-15
| -6% | -$2.54K | 0.02% | 207 |
|
|
2018
Q3 | $46K | Sell |
240
-21
| -8% | -$3.73K | 0.02% | 219 |
|
|
2018
Q2 | $42K | Hold |
261
| – | – | 0.02% | 236 |
|
|
2018
Q1 | $36K | Sell |
261
-36
| -12% | -$5.02K | 0.02% | 231 |
|
|
2017
Q4 | $36K | Sell |
297
-180
| -38% | -$22.5K | 0.01% | 227 |
|
|
2017
Q3 | $55K | Hold |
477
| – | – | 0.02% | 185 |
|
|
2017
Q2 | $50K | Hold |
477
| – | – | 0.02% | 194 |
|
|
2017
Q1 | $41K | Hold |
477
| – | – | 0.02% | 204 |
|
|
2016
Q4 | $34K | Sell |
477
-135
| -22% | -$9.93K | 0.02% | 198 |
|
|
2016
Q3 | $49K | Hold |
612
| – | – | 0.02% | 144 |
|
|
2016
Q2 | $45K | Sell |
612
-198
| -24% | -$13.9K | 0.03% | 142 |
|
|
2016
Q1 | $54K | Hold |
810
| – | – | 0.03% | 127 |
|
|
2015
Q4 | $49K | Hold |
810
| – | – | 0.02% | 135 |
|
|
2015
Q3 | $41K | Hold |
810
| – | – | 0.02% | 137 |
|
|
2015
Q2 | $44K | Hold |
810
| – | – | 0.02% | 151 |
|
|
2015
Q1 | $45K | Hold |
810
| – | – | 0.03% | 146 |
|
|
2014
Q4 | $48K | Hold |
810
| – | – | 0.03% | 148 |
|
|
2014
Q3 | $42K | Hold |
810
| – | – | 0.03% | 155 |
|
|
2014
Q2 | $37K | Hold |
810
| – | – | 0.02% | 163 |
|
|
2014
Q1 | $39K | Hold |
810
| – | – | 0.02% | 154 |
|
|
2013
Q4 | $35K | Hold |
810
| – | – | 0.02% | 161 |
|
|
2013
Q3 | $34K | Hold |
810
| – | – | 0.02% | 165 |
|
|
2013
Q2 | $46K | Buy |
+810
| New | +$44.6K | 0.03% | 168 |
|
Other funds holding ISRG
AlphaMark Advisors's ISRG Position: Q4 2024 in Review
AlphaMark Advisors increased its Intuitive Surgical (ISRG) stake by 300% in Q4 2024, buying an estimated $37.5K and bringing the position to 96 shares worth $50K. The position accounts for 0.02% of the portfolio, ranked #245.
AlphaMark Advisors first reported a position in ISRG in Q2 2013 and has held it in 47 quarters since. The position peaked at $55K in Q3 2017. 2,130 funds tracked by Wall St. Rank hold ISRG as of Q4 2024.
- AlphaMark Advisors held 96 shares of Intuitive Surgical worth $50K as of Q4 2024.
- AlphaMark Advisors bought 72 Intuitive Surgical shares in Q4 2024, an estimated $37.5K.
- Intuitive Surgical made up 0.02% of AlphaMark Advisors's portfolio in Q4 2024, its #245 holding.
- AlphaMark Advisors first reported a position in Intuitive Surgical in Q2 2013 and has held it in 47 quarters since.
- AlphaMark Advisors's Intuitive Surgical position peaked at $55K in Q3 2017.
- 2,130 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.